Fellow short1---The fact that the current administration has not made prosecution of patients and caregivers working with prescribed medical marijuana in the states that allow it does not change the fact that it is still a violation of federal law. The article you linked to also makes it clear specifically who they intend to leave alone stating:
"In a memorandum to federal prosecutors in the 14 states that make some allowance for the use of marijuana for medical purposes, the department said that it was committed to the “efficient and rational use” of its resources and that prosecuting patients and distributors who are in “clear and unambiguous compliance” with state laws did not meet that standard.
The new stance was hardly an enthusiastic embrace of medical marijuana, or the laws that allow it in some states, but signaled clearly that the administration thought there were more important priorities for prosecutors.
“It will not be a priority to use federal resources to prosecute patients with serious illnesses or their caregivers who are complying with state laws on medical marijuana,” Attorney General Eric H. Holder Jr. said in a statement accompanying the memo"
This relaxation does not apply to a supplement company as the article also states:
"marijuana has not withstood the rigors of science — it is not medicine and it is not safe. D.E.A. targets criminals engaged in cultivation and trafficking, not the sick and dying.”"
To further the point, that article was written in 2009 and as of today the official government policy on Pot and THC --directly from whitehouse.gov is as follows:
"Marijuana is classified as a Schedule I controlled substance under the Controlled Substances Act (CSA). As a Schedule I drug, marijuana is classified under the following criteria:
A. The drug has a high potential for abuse.
B. The drug has no currently accepted medical use in treatment in the United States
C. There is a lack of accepted safety for use of the drug under medical supervision.
The CSA mandates that the scheduling and approval of drugs, including marijuana, must be done on both legal and scientific bases. The scheduling of a drug must conform to all applicable criteria contained in the CSA if the medicine includes a controlled substance. In June 2011, the Drug Enforcement Administration (DEA) reviewed a petition to reschedule marijuana. Based upon scientific and medical evaluation, as well as scheduling recommendations from the Department of Health and Human Services (HHS), DEA denied the petition to reschedule marijuana. HHS determined that marijuana has a high potential for abuse, no currently accepted medical use in treatment in the U.S., and lacks accepted safety for use under medical supervision.
Regardless of state laws to the contrary, there is no such thing as “medical” marijuana under Federal law. Marijuana continues to be a Schedule I substance meaning that it has no currently accepted medical use and a high potential for abuse."
With respect to the DOJ guidelines addressed in your article, whitehouse.gov goes on to sspecify:
"The DOJ guidelines do not legalize marijuana. The DOJ guidance explicitly states that marijuana remains illegal under Federal law."
So I will repeat what I said in my last post---The company specifically stated that their possession, use, and distribution of THC containing products does not violate federal law. This is a blatantly and purposefully false statement made with intent to deceive investors of a publicly traded company.
In other words it is securities fraud
